Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal morphological and functional changes associated with platelet-derived growth factor B.

Davide Cina1, Pranali Patel, Jessica C Bethune

  • 1Department of Medicine, McMaster University, Hamilton, ON, Canada.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|September 9, 2008
PubMed
Summary

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver transplant recipient with right lobe ischemia and transaminitis 1-month posttransplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

HLA-DQ monomer-based enrichment of alloreactive CD4 T cells.

bioRxiv : the preprint server for biology·2025
Same author

PCFT-Independent Cellular Uptake of Cyclic Cell-Penetrating Peptide-Conjugated Folic Acid.

Chembiochem : a European journal of chemical biology·2025
Same author

In vitro expression of genes encoding HIF1α, VEGFA, PGE2 synthases, and PGE2 receptors in feline oral squamous cell carcinoma.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2025
Same author

Correction: Nazeer et al. Bacterial-Specific Aggregation and Killing of Immunomodulatory Host Defense Peptides. <i>Pharmaceuticals</i> 2021, <i>14</i>, 839.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Implications of MHC-restricted immunopeptidome in transplantation.

Frontiers in immunology·2024

Platelet-derived growth factor (PDGF) induced blood vessel growth in the peritoneum but did not cause fibrosis or significant ultrafiltration issues. PDGF-B may contribute to peritoneal dialysis complications but is not the sole factor.

Area of Science:

  • Nephrology
  • Cell Biology
  • Tissue Engineering

Background:

  • Long-term peritoneal dialysis (PD) can cause peritoneal membrane changes like angiogenesis, fibrosis, and epithelial-mesenchymal transition.
  • Platelet-derived growth factor (PDGF) is linked to these injury responses.

Purpose of the Study:

  • To investigate the role of PDGF-B in inducing morphological and functional changes in the rat peritoneal membrane.
  • To assess if PDGF-B contributes to fibrosis and epithelial-mesenchymal transition relevant to PD complications.

Main Methods:

  • Rats received intraperitoneal injections of an adenoviral vector expressing PDGF-B.
  • Peritoneal membrane structure and function were analyzed post-sacrifice.
  • Gene expression related to epithelial-mesenchymal transition was assessed.

Related Experiment Videos

Main Results:

  • PDGF-B overexpression led to significant angiogenesis, cell proliferation, and submesothelial thickening.
  • While transforming growth factor beta expression increased, its activation was limited, preventing significant collagen accumulation.
  • Increased solute transport was observed, but ultrafiltration function was only transiently and insignificantly impacted.
  • No evidence of epithelial-mesenchymal transition was found, and mesothelial cells showed increased collagen gene expression.

Conclusions:

  • PDGF-B induces peritoneal angiogenesis without causing fibrosis.
  • The absence of significant ultrafiltration dysfunction and epithelial-mesenchymal transition suggests PDGF-B is not the sole driver of PD-related peritoneal injury.